Ameriprise’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-266,885
| Closed | -$24.8M | – | 4078 |
|
|
2021
Q4 | $24.8M | Buy |
266,885
+7,096
| +3% | +$467K | 0.01% | 1250 |
|
|
2021
Q3 | $15.5M | Buy |
259,789
+64,636
| +33% | +$3.82M | ﹤0.01% | 1482 |
|
|
2021
Q2 | $13.3M | Buy |
195,153
+31,391
| +19% | +$2.05M | ﹤0.01% | 1684 |
|
|
2021
Q1 | $11.4M | Sell |
163,762
-13,738
| -8% | -$1.06M | ﹤0.01% | 1774 |
|
|
2020
Q4 | $13.6M | Sell |
177,500
-15,833
| -8% | -$1.19M | ﹤0.01% | 1512 |
|
|
2020
Q3 | $14.5M | Buy |
193,333
+48,594
| +34% | +$3.24M | 0.01% | 1287 |
|
|
2020
Q2 | $9.11M | Buy |
144,739
+78,659
| +119% | +$4.33M | ﹤0.01% | 1597 |
|
|
2020
Q1 | $2.77M | Buy |
66,080
+38,523
| +140% | +$1.77M | ﹤0.01% | 2291 |
|
|
2019
Q4 | $1.25M | Buy |
27,557
+9,096
| +49% | +$430K | ﹤0.01% | 2964 |
|
|
2019
Q3 | $845K | Sell |
18,461
-20,064
| -52% | -$1.13M | ﹤0.01% | 3088 |
|
|
2019
Q2 | $2.26M | Buy |
38,525
+15,289
| +66% | +$790K | ﹤0.01% | 2677 |
|
|
2019
Q1 | $1.04M | Buy |
+23,236
| New | +$1.07M | ﹤0.01% | 3028 |
|
|
2018
Q3 | – | Sell |
-33,155
| Closed | -$1.45M | – | 3805 |
|
|
2018
Q2 | $1.45M | Buy |
+33,155
| New | +$1.42M | ﹤0.01% | 2869 |
|
|
2015
Q4 | – | Sell |
-92,686
| Closed | -$1.77M | – | 3956 |
|
|
2015
Q3 | $1.77M | Buy |
92,686
+63,856
| +221% | +$2.17M | ﹤0.01% | 2680 |
|
|
2015
Q2 | $1.34M | Buy |
+28,830
| New | +$1.25M | ﹤0.01% | 2973 |
|
|
2014
Q4 | – | Sell |
-466
| Closed | -$19K | – | 4596 |
|
|
2014
Q3 | $19K | Buy |
466
+69
| +17% | +$3.08K | ﹤0.01% | 4510 |
|
|
2014
Q2 | $24K | Sell |
397
-2
| -0.5% | -$126 | ﹤0.01% | 4246 |
|
|
2014
Q1 | $25K | Sell |
399
-64
| -14% | -$4.25K | ﹤0.01% | 4103 |
|
|
2013
Q4 | $28K | Sell |
463
-1,349
| -74% | -$70.5K | ﹤0.01% | 3913 |
|
|
2013
Q3 | $96K | Sell |
1,812
-8
| -0.4% | -$537 | ﹤0.01% | 3478 |
|
|
2013
Q2 | $141K | Buy |
+1,820
| New | +$149K | ﹤0.01% | 3238 |
|
Ameriprise's ARNA Position: Q1 2022 in Review
Ameriprise sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 266,885 shares — an estimated $24.8M sold.
Ameriprise first reported a position in ARNA in Q2 2013 and held it in 21 quarters. The position peaked at $24.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Ameriprise reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Ameriprise sold 266,885 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $24.8M.
- Ameriprise first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 21 quarters.
- Ameriprise's Arena Pharmaceuticals Inc position peaked at $24.8M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.